Skip to main content
OpenTrials

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

490 public trials 154 recruiting studies
Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Recruiting

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

NCT07169734

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • The University of Chicago Medical Center - Oncology Chicago, Illinois, United States
View all 41 locations
View Trial Details
Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

NCT07488676

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +15 more
Locations
  • UAB Medicine - UAB Hospital Birmingham, Alabama, United States
  • START Los Angeles Los Angeles, California, United States
  • Indiana University (IU) Health - Multi-D Oncology Clinic Indianapolis, Indiana, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 14 locations
View Trial Details
Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

NCT07265674

Conditions
Adenocarcinoma, Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC), +12 more
Locations
  • City of Hope (Site 107) Duarte, California, United States
  • University of California at Irvine (Site 101) Orange, California, United States
  • UCLA Medical Center (Site 117) Santa Monica, California, United States
  • Moffitt Cancer Center Magnolia Campus (Site 123) Tampa, Florida, United States
View all 18 locations
View Trial Details
Recruiting

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NCT07458347

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +44 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

NCT06607302

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations
  • Hämatologisch-Onkologische Schwerpunktpraxis in Bad Liebenwerda Bad Liebenwerda, Germany
  • Caritas Krankenhaus Bad Mergentheim Bad Mergentheim, Germany
  • Onkologisches Versorgungszentrum Berlin MVZ Berlin, Germany
  • Gemeinschaftspraxis Hämatologie - Onkologie Dresden, Germany
View all 13 locations
View Trial Details

Related conditions